Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indo US Bio-TechBOM:541304 -4.01%77 Pretax Margin % is 9.33% as of Jun. 2026, which is 9% below its 10-year median of 10.21. GuruFocus rates BOM:541304 with a GF Score™ of 77/100 and a GF Value™ of ₹298.00 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 250 Agriculture companies, Indo US Bio-Tech ranks better than 73.2% on this metric.
Indo US Bio-Tech (BOM:541304) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Indo US Bio-Tech Pretax Margin % Related Terms
Indo US Bio-Tech Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:541304 vs CTVA, CF, MOS: Pretax Margin % Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech Pretax Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech (BOM:541304) has a Pretax Margin % of 9.33% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Indo US Bio-Tech and its competitors. This is near median its historical median of 10.21. Over the past decade, Indo US Bio-Tech's Pretax Margin % has ranged from 2.13 to 15.92. According to the industry distribution chart, Indo US Bio-Tech ranks #67 out of 250 companies in the Agriculture industry, placing it in the top 26.8%.
Is Indo US Bio-Tech's Pretax Margin % too high?
Indo US Bio-Tech's current Pretax Margin % of 9.33% is near median its 10-year median of 10.21. Over the past 10 years, this metric has ranged from a low of 2.13 to a high of 15.92. The Agriculture industry median Pretax Margin % is 6.12. Indo US Bio-Tech's value of 9.33% is 52.6% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #67 out of 250 companies in the Agriculture industry, which is above the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Pretax Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #67 out of 250 companies for Pretax Margin %. This puts Indo US Bio-Tech in the upper half of its industry. The industry median Pretax Margin % is 6.12. Indo US Bio-Tech's value of 9.33% is 52.6% above this benchmark. Historically, Indo US Bio-Tech's own Pretax Margin % has ranged from 2.13 to 15.92 over the past decade. While the company's 10-year median is 10.21 vs. the industry median of 6.12, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for an Agriculture company?
The median Pretax Margin % among Agriculture companies is 6.12, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current Pretax Margin % of 9.33% is 52.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median Pretax Margin % is 6.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current Pretax Margin % is 9.33%, which is near median its own 10-year median of 10.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (BOM:541304) is currently considered Possible Value Trap. The stock's GF Value™ is ₹298.00, compared to a current price of ₹77.20 — trading 74.1% below its estimated fair value. The current Pretax Margin % is 9.33%, which is near median its 10-year median of 10.21 and 52.6% above the Agriculture industry median of 6.12. Indo US Bio-Tech's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Indo US Bio-Tech (BOM:541304), the current Pretax Margin % is 9.33% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (BOM:541304) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹77.20 is trading 74.1% below its estimated GF Value™ of ₹298.00.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for BOM:541304:
Pretax Margin %: 9.33% (near median its 10-year median of 10.21)
GF Value™: ₹298.00 vs. price of ₹77.20 (74.1% below fair value)
Industry Position: 52.6% above the Agriculture median (#67 of 250)
No single metric tells the full story. See the BOM:541304 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is an Indian agriculture seed company engaged in crop research, breeding, seed production, processing, packing, and marketing. It develops and sells hybrid and open-pollinated seed varieties, with a portfolio spanning vegetable seeds such as tomato, okra, brinjal, onion, cucumber, and bottle gourd, along with oilseeds including groundnut and mustard, pulses, cereals such as wheat and bajra, and spice seeds. The company serves farmers and agricultural distributors across India through its seed brands and dealer network. Its revenue model centers on the sale of packaged seeds to the agricultural market, supported by in-house research and development, contract seed multiplication, and processing facilities. By offering improved varieties with traits such as higher yield and disease tolerance, Indo US Bio-Tech positions itself in the domestic hybrid seed segment of India's input agriculture industry.
77GF Score
Get the complete analysis for BOM:541304
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:541304 has been successfully added to your 
